MET and cervical cancer: The cervical cancer group demonstrated a higher c-Met expression (RR = 2.13; 95% CI: 1.02–4.44, P = 0.044) and moderate heterogeneity (I2 = 83.3%, P = 0.0001) compared with the neoplasia group (Figure 2(c)).